Does Health Canada approval mean my province will pay for Ozempic?

No. Health Canada authorization allows the product to be marketed in Canada. Provincial and territorial drug plans decide independently whether to list a drug, and on what terms.

Is Ozempic on national pharmacare everywhere?

National pharmacare lists apply only in jurisdictions with a signed bilateral agreement and only for categories published in the official annexes. As of the sources reviewed here, that includes BC, Manitoba, PEI, and Yukon for selected medication lists, not all of Canada.

Can I use public and private coverage together?

Often yes, but coordination rules vary. Some private plans require you to apply public benefits first; others exclude drugs already paid by a public plan. Read both plan booklets or ask your insurer.

Does this guide cover Ozempic for weight loss?

No. This guide focuses on administrative coverage pathways for the diabetes-related product marketed as Ozempic in Canada. Other semaglutide brands and indications follow different formularies and policies.

Can MyEligible tell me my exact copay?

No. Tools on MyEligible link to official lists and explain plan pathways. Only your insurer, public plan administrator, or pharmacy claim response can confirm what you will pay.

Drug coverage · Diabetes medicines

Ozempic coverage in Canada: public plans, pharmacare, and private insurance

Ozempic is a brand-name semaglutide injection approved by Health Canada for treating type 2 diabetes in adults, and for reducing cardiovascular risk in some adults with type 2 diabetes and established cardiovascular disease. Whether your out-of-pocket cost is reduced depends on drug plan rules, not on this guide.

This page explains administrative pathways only: how public and private drug programs in Canada usually handle prescription coverage, where national pharmacare lists may apply, and which official sources to check. It does not recommend treatment, dosing, or whether Ozempic is appropriate for you.

At a glance

Health Canada approval means the product may be sold in Canada; it does not set provincial reimbursement or your copay.
Each province and territory runs its own public drug programs (for example Ontario Drug Benefit, BC PharmaCare, RAMQ drug insurance in Québec). Formulary status and restrictions differ.
Canada has signed national pharmacare bilateral agreements with British Columbia, Manitoba, Prince Edward Island, and Yukon. Published lists in those jurisdictions may include diabetes medications; use the official list for your province rather than assuming coverage.
Employer or private insurance may cover Ozempic under a separate policy. Patient support programs from the manufacturer are commercial arrangements, not government benefits.

What this guide covers

Coverage administration only, with links to official plan materials.

Use this guide if you already have an Ozempic prescription or are trying to understand plan paperwork, prior authorization, or formulary language. We focus on where to look in public formularies, how national pharmacare lists fit in participating provinces, and how private plans may layer on top.

MyEligible does not store your medical history or insurance details. Tools on this site can point to official formulary search pages or published national pharmacare lists; they do not guarantee that you will be reimbursed.

What we do not cover here

We do not provide dosing instructions, side-effect counselling, weight-management advice, or comparisons between GLP-1 medicines. For clinical questions, speak with a regulated health professional. For plan-specific copays and authorization forms, contact your insurer or public plan administrator.

Public drug plans in Canada

Provincial and territorial programs set formulary listing, deductibles, and authorization rules.

Most Canadians access prescription drug coverage through a mix of public programs (often income-tested or age-based), federal programs for First Nations and Inuit clients, and private workplace insurance. Ozempic may appear on a formulary as a regular benefit, a limited-use benefit, a special authorization drug, or not at all, depending on the plan and indication on file.

Formularies update on schedules set by each jurisdiction. A drug that was not listed last year may be listed today with new criteria, or vice versa. Always check the current published formulary or official search tool for the plan that would pay your claim.

Typical factors public plans consider (wording varies by province) include diagnosis on the claim, age, other diabetes medicines tried, and prescriber attestation forms.

National pharmacare lists (participating provinces)

Bilateral agreements cover selected medication categories in BC, Manitoba, PEI, and Yukon only.

The Government of Canada and Health Canada publish national pharmacare bilateral agreements with individual provinces and territories. As of the sources reviewed for this page, participating jurisdictions include British Columbia, Manitoba, Prince Edward Island, and Yukon. Other provinces and territories continue to rely on their existing public drug programs outside these agreements.

Where a national pharmacare list exists for diabetes medications, coverage still depends on meeting list criteria and enrolling in the applicable public plan. British Columbia publishes Plan NP diabetes medication materials on gov.bc.ca; other participating provinces publish their own annexes and search tools on canada.ca and provincial sites.

If you live outside BC, Manitoba, PEI, or Yukon, national pharmacare lists do not replace your provincial or territorial formulary. Use the public drug coverage navigator for handoffs to official plan pages where MyEligible does not hold a complete formulary feed.

Open national pharmacare checker

Check coverage where you live

Use official formulary search tools rather than informal province summaries.

MyEligible intentionally avoids province-by-province Ozempic reimbursement claims in this guide because formularies change and authorization rules are detailed. Instead, open the public drug coverage navigator, select your province or territory, and follow the official formulary or plan links provided there.

Where MyEligible ingests published formulary data, the public drug coverage medication check may show whether a DIN matches a published entry and whether restrictions apply. That result is informational: your pharmacy adjudication at the point of sale is authoritative.

Open public drug coverage navigator

Private insurance and out-of-pocket help

Workplace plans and patient support programs follow their own contracts.

If you have employer-sponsored or individual drug insurance, your certificate of coverage lists deductibles, copays, prior authorization, and any step-therapy rules. Insurers may cover Ozempic for diabetes indications while excluding other uses; read your policy or call the insurer’s pharmacy help line.

Manufacturers sometimes offer co-pay cards or support programs subject to eligibility rules and privacy policies. These are not government benefits and may change without notice. Verify details on the manufacturer’s official Canadian site if you choose to explore them.

Steps to verify coverage

Confirm the prescription details your pharmacy will submit (brand, strength, DIN if available, and diagnosis code your prescriber uses).
Identify which plan pays first: public plan, federal program, or private insurer. Many households coordinate benefits; your pharmacy can often tell you which card to present first.
Open the public drug coverage navigator for your province or territory and follow the official formulary or plan link. If you live in BC, Manitoba, PEI, or Yukon, also review the national pharmacare checker for published list entries.
If the formulary shows special authorization or limited use, ask your prescriber whether the required forms match your clinical record. MyEligible does not submit authorization requests.
Before filling a long supply, confirm expected copay with your pharmacy or insurer. Appeals processes differ by plan; use the plan’s published appeal or reconsideration page if a claim is denied.

Common questions

Official sources

Last reviewed for this tool: 2026-09-27. Amounts may change.